FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153886504> ?p ?o ?g. }

• W2153886504 endingPage "287" @default.
• W2153886504 startingPage "275" @default.
• W2153886504 abstract "A series of unknown 3-(alkyl(dialkyl)amino)benzofuro[2,3-f]quinazolin-1(2H)-ones 4-17 has been synthesized as new ellipticine analogs, in which the carbazole moiety and the pyridine ring were replaced by a dibenzofuran residue and a pyrimidine ring, respectively. The synthesis of these benzofuroquinazolinones 4-17 was performed in a simple one-pot reaction using 3-aminodibenzofuran or its 2-methoxy derivative, as starting materials. From 3-(dipropylamino)-5-methoxybenzofuro[2,3-f] quinazolin-1(2H)-one (13), we prepared 3-(dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (18), referred to as DPA-HBFQ-1. The cytotoxic activities of all the synthesized compounds, tested in different human breast cancer cell lines, revealed that DPA-HBFQ-1 was the most active compound. In particular, the latter was able to inhibit anchorage-dependent and -independent cell growth and to induce apoptosis in estrogen receptor alpha (ERα)-positive and -negative breast cancer cells. It did not affect proliferation and apoptotic responses in MCF-10A normal breast epithelial cells. The observed effects have been ascribed to an enhanced p21(Cip1/WAF1) expression in a p53-dependent manner of tumor suppressor and to a selective inhibition of human topoisomerase II. In addition, DPA-HBFQ-1 exerted growth inhibitory effects also in other cancer cell lines, even though with a lower cytotoxic activity. Our results indicate DPA-HBFQ-1 as a good candidate to be useful as cancer therapeutic agent, particularly for breast cancer." @default.
• W2153886504 created "2016-06-24" @default.
• W2153886504 creator A5001667942 @default.
• W2153886504 creator A5005529667 @default.
• W2153886504 creator A5007339780 @default.
• W2153886504 creator A5010396157 @default.
• W2153886504 creator A5013221500 @default.
• W2153886504 creator A5018243857 @default.
• W2153886504 creator A5018496506 @default.
• W2153886504 creator A5022037891 @default.
• W2153886504 creator A5036678266 @default.
• W2153886504 creator A5037298250 @default.
• W2153886504 creator A5039725997 @default.
• W2153886504 creator A5047748434 @default.
• W2153886504 creator A5065512430 @default.
• W2153886504 creator A5067264105 @default.
• W2153886504 creator A5089369776 @default.
• W2153886504 date "2016-01-01" @default.
• W2153886504 modified "2023-09-29" @default.
• W2153886504 title "3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression" @default.
• W2153886504 cites W1545695993 @default.
• W2153886504 cites W1965689906 @default.
• W2153886504 cites W1973078771 @default.
• W2153886504 cites W1974264764 @default.
• W2153886504 cites W1974517960 @default.
• W2153886504 cites W1975673877 @default.
• W2153886504 cites W1976690209 @default.
• W2153886504 cites W1979692390 @default.
• W2153886504 cites W1981231408 @default.
• W2153886504 cites W1985496352 @default.
• W2153886504 cites W1986256719 @default.
• W2153886504 cites W1986880443 @default.
• W2153886504 cites W1992359985 @default.
• W2153886504 cites W1992558564 @default.
• W2153886504 cites W1994761772 @default.
• W2153886504 cites W2007348883 @default.
• W2153886504 cites W2011445639 @default.
• W2153886504 cites W2014330039 @default.
• W2153886504 cites W2015519364 @default.
• W2153886504 cites W2018644879 @default.
• W2153886504 cites W2020236755 @default.
• W2153886504 cites W2020830322 @default.
• W2153886504 cites W2025536051 @default.
• W2153886504 cites W2025814748 @default.
• W2153886504 cites W2026130558 @default.
• W2153886504 cites W2028101098 @default.
• W2153886504 cites W2029319917 @default.
• W2153886504 cites W2031169679 @default.
• W2153886504 cites W2031291993 @default.
• W2153886504 cites W2034454289 @default.
• W2153886504 cites W2034607919 @default.
• W2153886504 cites W2035550656 @default.
• W2153886504 cites W2038173255 @default.
• W2153886504 cites W2039056764 @default.
• W2153886504 cites W2039920192 @default.
• W2153886504 cites W2040709804 @default.
• W2153886504 cites W2042658426 @default.
• W2153886504 cites W2047431110 @default.
• W2153886504 cites W2061831020 @default.
• W2153886504 cites W2070991922 @default.
• W2153886504 cites W2077301074 @default.
• W2153886504 cites W2078981960 @default.
• W2153886504 cites W2086141764 @default.
• W2153886504 cites W2089720091 @default.
• W2153886504 cites W2093290623 @default.
• W2153886504 cites W2094319649 @default.
• W2153886504 cites W2095797462 @default.
• W2153886504 cites W2099638288 @default.
• W2153886504 cites W2100312975 @default.
• W2153886504 cites W2106787323 @default.
• W2153886504 cites W2110576169 @default.
• W2153886504 cites W2114819729 @default.
• W2153886504 cites W2123331670 @default.
• W2153886504 cites W2125034535 @default.
• W2153886504 cites W2131316166 @default.
• W2153886504 cites W2131377054 @default.
• W2153886504 cites W2132090721 @default.
• W2153886504 cites W2136833945 @default.
• W2153886504 cites W2138388945 @default.
• W2153886504 cites W2138911924 @default.
• W2153886504 cites W2142712029 @default.
• W2153886504 cites W2299729257 @default.
• W2153886504 cites W2306851511 @default.
• W2153886504 cites W2328086829 @default.
• W2153886504 cites W2330899520 @default.
• W2153886504 cites W2338176001 @default.
• W2153886504 cites W2950354719 @default.
• W2153886504 cites W2952597817 @default.
• W2153886504 cites W4239524565 @default.
• W2153886504 doi "https://doi.org/10.1016/j.ejmech.2015.11.004" @default.
• W2153886504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26599533" @default.
• W2153886504 hasPublicationYear "2016" @default.
• W2153886504 type Work @default.
• W2153886504 sameAs 2153886504 @default.
• W2153886504 citedByCount "37" @default.
• W2153886504 countsByYear W21538865042017 @default.
• W2153886504 countsByYear W21538865042018 @default.
• W2153886504 countsByYear W21538865042019 @default.

• next